• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于疾病进展的隐藏移动-停留模型,考虑到分类错误和部分观察到的诊断测试:在人乳头瘤病毒和宫颈癌前病变自然史中的应用。

Hidden mover-stayer model for disease progression accounting for misclassified and partially observed diagnostic tests: Application to the natural history of human papillomavirus and cervical precancer.

机构信息

Biostatistics Branch, Division of Cancer and Epidemiology, National Cancer Institute, Rockville, Maryland, USA.

Clinical Genetics Branch, Division of Cancer and Epidemiology, National Cancer Institute, Rockville, Maryland, USA.

出版信息

Stat Med. 2021 Jul 10;40(15):3460-3476. doi: 10.1002/sim.8977. Epub 2021 Apr 12.

DOI:10.1002/sim.8977
PMID:33845514
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10257883/
Abstract

Hidden Markov models (HMMs) have been proposed to model the natural history of diseases while accounting for misclassification in state identification. We introduce a discrete time HMM for human papillomavirus (HPV) and cervical precancer/cancer where the hidden and observed state spaces are defined by all possible combinations of HPV, cytology, and colposcopy results. Because the population of women undergoing cervical cancer screening is heterogeneous with respect to sexual behavior, and therefore risk of HPV acquisition and subsequent precancers, we use a mover-stayer mixture model that assumes a proportion of the population will stay in the healthy state and are not subject to disease progression. As each state is a combination of three distinct tests that characterize the cervix, partially observed data arise when at least one but not every test is observed. The standard forward-backward algorithm, used for evaluating the E-step within the E-M algorithm for maximum-likelihood estimation of HMMs, cannot incorporate time points with partially observed data. We propose a new forward-backward algorithm that considers all possible fully observed states that could have occurred across a participant's follow-up visits. We apply our method to data from a large management trial for women with low-grade cervical abnormalities. Our simulation study found that our method has relatively little bias and out preforms simpler methods that resulted in larger bias.

摘要

隐马尔可夫模型 (HMM) 已被提出用于在状态识别中考虑分类错误的情况下对疾病的自然史进行建模。我们引入了一种用于人乳头瘤病毒 (HPV) 和宫颈癌前病变/癌症的离散时间 HMM,其中隐藏状态和观察状态空间由 HPV、细胞学和阴道镜检查结果的所有可能组合定义。由于接受宫颈癌筛查的女性群体在性行为方面存在异质性,因此 HPV 感染和随后的癌前病变的风险也不同,我们使用了一个移动者-停留者混合模型,假设一部分人群将保持健康状态,不会发生疾病进展。由于每个状态都是三个不同测试的组合,这些测试描述了宫颈的状态,因此当至少有一个但不是所有测试都被观察到时,就会出现部分观察数据。标准的前向后向算法用于评估 E-M 算法中最大似然估计 HMM 的 E 步,无法包含部分观察数据的时间点。我们提出了一种新的前向后向算法,该算法考虑了在参与者的随访过程中可能发生的所有完全观察到的状态。我们将我们的方法应用于来自一个大型管理试验的低级别宫颈异常女性的数据。我们的模拟研究发现,我们的方法具有相对较小的偏差,并且表现优于导致更大偏差的简单方法。

相似文献

1
Hidden mover-stayer model for disease progression accounting for misclassified and partially observed diagnostic tests: Application to the natural history of human papillomavirus and cervical precancer.用于疾病进展的隐藏移动-停留模型,考虑到分类错误和部分观察到的诊断测试:在人乳头瘤病毒和宫颈癌前病变自然史中的应用。
Stat Med. 2021 Jul 10;40(15):3460-3476. doi: 10.1002/sim.8977. Epub 2021 Apr 12.
2
Human papillomavirus-based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial.基于人乳头瘤病毒(HPV)的筛查在延长的间隔时间内发现的宫颈癌前病变比细胞学检查少,这在 HPV 用于宫颈癌(HPV FOCAL)试验中得到了证实。
Int J Cancer. 2022 Sep 15;151(6):897-905. doi: 10.1002/ijc.34039. Epub 2022 May 10.
3
Cervical Cancer Screening: A Review.宫颈癌筛查:综述。
JAMA. 2023 Aug 8;330(6):547-558. doi: 10.1001/jama.2023.13174.
4
A prospective study of risk-based colposcopy demonstrates improved detection of cervical precancers.一项基于风险的阴道镜检查的前瞻性研究显示,可提高宫颈癌前病变的检出率。
Am J Obstet Gynecol. 2018 Jun;218(6):604.e1-604.e8. doi: 10.1016/j.ajog.2018.02.009. Epub 2018 Feb 17.
5
[Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].[卫生技术评估报告:基于人乳头瘤病毒DNA的宫颈癌前病变初筛]
Epidemiol Prev. 2012 May-Aug;36(3-4 Suppl 1):e1-72.
6
National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study.澳大利亚 HPV 疫苗接种人群中前两年 HPV 宫颈筛查的国家经验:观察性研究。
BMJ. 2022 Mar 30;376:e068582. doi: 10.1136/bmj-2021-068582.
7
Understanding the role of oncogenic human papillomavirus (HPV) status on adherence behaviors among women with abnormal cervical cytology.了解致癌型人乳头瘤病毒(HPV)状态对宫颈细胞学异常女性的依从性行为的影响。
BMC Womens Health. 2021 Jan 18;21(1):29. doi: 10.1186/s12905-020-01168-2.
8
The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.IMproving Primary Screening And Colposcopy Triage 试验:人乳头瘤病毒、宫颈细胞学和组织病理学结果,来自基线和 1 年随访阶段。
Am J Obstet Gynecol. 2021 Sep;225(3):278.e1-278.e16. doi: 10.1016/j.ajog.2021.03.047. Epub 2021 Apr 20.
9
Extension of cervical screening intervals with primary human papillomavirus testing: observational study of English screening pilot data.以人乳头瘤病毒检测为基础的宫颈癌筛查间隔时间的延长:英国筛查试点数据的观察性研究。
BMJ. 2022 May 31;377:e068776. doi: 10.1136/bmj-2021-068776.
10
[Performance of combined liquid based cytology and HPV nucleic acid test for detecting cervical precancer among women attending screening].[联合液基细胞学和人乳头瘤病毒核酸检测在筛查女性中检测宫颈癌前病变的性能]
Zhonghua Zhong Liu Za Zhi. 2018 Oct 23;40(10):750-756. doi: 10.3760/cma.j.issn.0253-3766.2018.10.006.

引用本文的文献

1
Multistate models for the natural history of cancer progression.癌症进展自然史的多状态模型。
Br J Cancer. 2022 Oct;127(7):1279-1288. doi: 10.1038/s41416-022-01904-5. Epub 2022 Jul 11.

本文引用的文献

1
Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines.支持 2019 ASCCP 基于风险的管理共识指南的风险估计。
J Low Genit Tract Dis. 2020 Apr;24(2):132-143. doi: 10.1097/LGT.0000000000000529.
2
Accuracy of cervical cytology: comparison of diagnoses of 100 Pap smears read by four pathologists at three hospitals in Norway.宫颈细胞学检查的准确性:挪威三家医院的四位病理学家对100份巴氏涂片诊断结果的比较。
BMC Clin Pathol. 2017 Aug 29;17:18. doi: 10.1186/s12907-017-0058-8. eCollection 2017.
3
By how much could screening by primary human papillomavirus testing reduce cervical cancer incidence in England?通过原发性人乳头瘤病毒检测进行筛查能在多大程度上降低英国宫颈癌的发病率?
J Med Screen. 2017 Jun;24(2):110-112. doi: 10.1177/0969141316654197. Epub 2016 Jun 30.
4
Multiple biopsies and detection of cervical cancer precursors at colposcopy.多次活检及阴道镜检查时宫颈癌前病变的检测
J Clin Oncol. 2015 Jan 1;33(1):83-9. doi: 10.1200/JCO.2014.55.9948. Epub 2014 Nov 24.
5
An updated natural history model of cervical cancer: derivation of model parameters.宫颈癌自然史更新模型:模型参数推导。
Am J Epidemiol. 2014 Sep 1;180(5):545-55. doi: 10.1093/aje/kwu159. Epub 2014 Jul 31.
6
Human papillomavirus infection and the multistage carcinogenesis of cervical cancer.人乳头瘤病毒感染与宫颈癌的多阶段癌变。
Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):553-60. doi: 10.1158/1055-9965.EPI-12-1406.
7
Number of cervical biopsies and sensitivity of colposcopy.宫颈活检数量与阴道镜检查的敏感性
Obstet Gynecol. 2006 Aug;108(2):264-72. doi: 10.1097/01.AOG.0000220505.18525.85.
8
Human papillomavirus DNA testing by PCR-ELISA and hybrid capture II from a single cytological specimen: concordance and correlation with cytological results.采用聚合酶链反应-酶联免疫吸附测定法(PCR-ELISA)和杂交捕获二代技术(Hybrid Capture II)对单个细胞学标本进行人乳头瘤病毒DNA检测:与细胞学结果的一致性和相关性
J Clin Virol. 2002 Aug;25(2):177-85. doi: 10.1016/s1386-6532(02)00007-0.
9
ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants.非典型鳞状细胞意义不明确-低度鳞状上皮内病变分流研究。试验参与者的设计、方法及特征
Acta Cytol. 2000 Sep-Oct;44(5):726-42. doi: 10.1159/000328554.
10
Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies.使用多种宫颈标本采集策略对基于聚合酶链反应(PCR)和杂交捕获的人乳头瘤病毒检测系统进行比较。
J Clin Microbiol. 1998 Nov;36(11):3248-54. doi: 10.1128/JCM.36.11.3248-3254.1998.